Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) reported a fourth quarter loss of $1.03 per share and revenue of $7.2 million, as the messenger RNA medicines company ...
March is Women’s History Month so for the next few weeks, we’re going to recognize the women who have come before us, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results